Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive
Christie, G.A.
Medical Journal of Australia 2(4): 185-189
1969
ISSN/ISBN: 0025-729X PMID: 4184973 Document Number: 474898
Document emailed within 1 workday
Related Documents
de Gennes, J.L.; Turpin, G.; Truffert, J. 1971: Thrombosis of the right internal carotid artery following continuous contraceptive treatment with chlormadinone acetate in a 28-year-old woman La Presse Medicale 79(8): 355-356Caruso, S.; Rugolo, S.; Agnello, C.; Romano, M.; Cianci, A. 2009: Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate Journal of Sexual Medicine 6(12): 3376-3384
Heskamp, M.-L.S.; Schramm, G.A.K. 2010: Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits Contraception 81(1): 49-56
Hadji, P.; Biskup, J.; Boekhoff, J.; Ziller, M.; Bonn, M.; Rovati, L. 2012: Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg Contraception 86(4): 359-365
Kerscher, M.; Reuther, T.; Krueger, N.; Buntrock, H. 2013: Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception Journal of the European Academy of Dermatology and Venereology: Jeadv 27(5): 601-608
Uras, R.; Orrù, M.; Pani, F.; Marotto, M.F.; Pilloni, M.; Guerriero, S.; Etzi, R.; Zedda, P.; Sorge, R.; Lello, S.; Melis, G.B.; Paoletti, A.M. 2010: Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome Contraception 82(2): 131-138
Anthuber, S.; Schramm, G.A.K.; Heskamp, M.-L.S. 2010: Six-month evaluation of the benefits of the low-dose combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg in young women: results of the prospective, observational, non-interventional, multicentre TeeNIS study Clinical Drug Investigation 30(4): 211-220
Grandi, G.; Napolitano, A.; Xholli, A.; Tirelli, A.; Di Carlo, C.; Cagnacci, A. 2015: Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(10): 774-778
Cheewadhanaraks, S.; Choksuchat, C.; Dhanaworavibul, K.; Liabsuetrakul, T. 2012: Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial Gynecologic and Obstetric Investigation 74(2): 151-156
Gahr, M.; Freudenmann, R.W.; Connemann, B.J.; Kölle, M.A.; Schönfeldt-Lecuona, C. 2014: Rapid relapse in depression following initialization of oral contraception with ethinyl estradiol and chlormadinone acetate General Hospital Psychiatry 36(2): 230.E1
Yildizhan, R.; Gokce, A.I.; Yildizhan, B.; Cim, N. 2015: Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(5): 396-400
Mansour, D.; Verhoeven, C.; Sommer, W.; Weisberg, E.; Taneepanichskul, S.; Melis, G.B.; Sundström-Poromaa, I.; Korver, T. 2011: Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 430-443
Kapur, R.; Stramrood, C.A.I.; Schutgens, R.E.G.; van Asbeck, B.Sweder. 2009: Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 14(2): 160-163
Jensen, J.T.; Archer, D.F.; Westhoff, C.L.; Nelson, A.L.; Graham, S.; Bernick, B. 2023: Satisfaction with a Segesterone Acetate and Ethinyl Estradiol Contraceptive Vaginal System Among Recent Oral Contraceptive or Hormonal Contraceptive Vaginal Ring Users Journal of Women's Health 32(7): 808-815
Busch, W.; Hagelschuer, H.; Gränz, G.; Richter, G.; Werner, K. 1979: Hormonal desexing of boars with chlormadinone acetate Archiv für Experimentelle Veterinarmedizin 33(1): 99-109
Guerra-Tapia, A.; Sancho Pérez, B. 2011: Ethinylestradiol/Chlormadinone acetate: dermatological benefits American Journal of Clinical Dermatology 12(Suppl 1): 3-11
Gómez Vázquez, M.; Navarra Amayuelas, R.ón.; Lamarca, M.; Baquedano, L.; Romero Ruiz, S.án.; Vilar-Checa, E.; Iniesta, M.D. 2011: Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders American Journal of Clinical Dermatology 12(Suppl 1): 13-19
Guerra-Tapia, A.; Sancho Pérez, B. 2011: Ethinylestradiol/Chlormadinone acetate: dermatological benefits American Journal of Clinical Dermatology 12(Suppl 1): 3-11
Bergsjo, P.; Koller, O. 1972: Low-dose chlormadinone acetate for contraception. Clinical experience International Journal of Fertility 17(1): 35-42
Koch, U.J.; Lorenz, F.; Danehl, K.; Ericsson, R.; Hasan, S.H.; Keyserlingk, D.V.; Lübke, K.; Mehring, M.; Römmler, A.; Schwartz, U.; Hammerstein, J. 1976: Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? a trend analysis in 15 volunteers Contraception 14(2): 117-135